NDC 0032-1212

Creon

Pancrelipase

Creon is a Oral Capsule, Delayed Release Pellets in the Human Prescription Drug category. It is labeled and distributed by Abbvie Inc.. The primary component is Pancrelipase Amylase; Pancrelipase Lipase; Pancrelipase Protease.

Product ID0032-1212_073421ec-2bf3-4a89-a442-c381ac401b43
NDC0032-1212
Product TypeHuman Prescription Drug
Proprietary NameCreon
Generic NamePancrelipase
Dosage FormCapsule, Delayed Release Pellets
Route of AdministrationORAL
Marketing Start Date2009-04-30
Marketing CategoryBLA / NDA
Application NumberBLA020725
Labeler NameAbbVie Inc.
Substance NamePANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE
Active Ingredient Strength60000 [USP'U]/1; [USP'U]/1; [USP'U]/1
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0032-1212-01

100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-1212-01)
Marketing Start Date2009-04-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0032-1212-07 [00032121207]

Creon CAPSULE, DELAYED RELEASE PELLETS
Marketing CategoryBLA
Application NumberBLA020725
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-04-30

NDC 0032-1212-13 [00032121213]

Creon CAPSULE, DELAYED RELEASE PELLETS
Marketing CategoryBLA
Application NumberBLA020725
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-11-20

NDC 0032-1212-46 [00032121246]

Creon CAPSULE, DELAYED RELEASE PELLETS
Marketing CategoryBLA
Application NumberBLA020725
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-04-30
Marketing End Date2014-03-31

NDC 0032-1212-56 [00032121256]

Creon CAPSULE, DELAYED RELEASE PELLETS
Marketing CategoryBLA
Application NumberBLA020725
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-06-27
Marketing End Date2013-03-25

NDC 0032-1212-01 [00032121201]

Creon CAPSULE, DELAYED RELEASE PELLETS
Marketing CategoryBLA
Application NumberBLA020725
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-04-30

Drug Details

Active Ingredients

IngredientStrength
PANCRELIPASE AMYLASE60000 [USP'U]/1

OpenFDA Data

SPL SET ID:073201aa-556d-4a70-918e-84e9616fd88d
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 863841
  • 863836
  • 1373327
  • 863829
  • 1373325
  • 855499
  • 1113042
  • 855503
  • 1113046
  • 855495
    • UPC Code
  • 0300321224018
  • 0300323016123
  • 0300321206076
  • 0300321212077
  • 0300321206014
  • 0300323016130
  • 0300321203709

    • NDC Crossover Matching brand name "Creon" or generic name "Pancrelipase"

    NDCBrand NameGeneric Name
    0032-1203CreonPancrelipase
    0032-1206CreonPancrelipase
    0032-1212CreonPancrelipase
    0032-1224CreonPancrelipase
    0032-3016CreonPancrelipase
    17856-1206CreonPancrelipase
    17856-1212CreonPancrelipase
    17856-1224CreonPancrelipase
    50458-341PANCREAZEPANCRELIPASE
    50458-342PANCREAZEPANCRELIPASE
    50458-343PANCREAZEPANCRELIPASE
    50458-346PANCREAZEPANCRELIPASE
    50458-347PANCREAZEPANCRELIPASE
    58914-112ViokacePancrelipase
    58914-117ViokacePancrelipase
    42865-300ZENPEPpancrelipase
    42865-302ZENPEPpancrelipase
    42865-303ZENPEPpancrelipase
    42865-304ZENPEPpancrelipase
    42865-305ZENPEPpancrelipase
    42865-306ZENPEPpancrelipase
    42865-307ZENPEPpancrelipase

    Trademark Results [Creon]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    CREON
    CREON
    79026305 3318553 Dead/Cancelled
    Abbott Products Operations AG
    2006-04-26
    CREON
    CREON
    74515321 1909701 Live/Registered
    ABBVIE PRODUCTS LLC
    1994-04-22
    CREON
    CREON
    73613769 1443810 Dead/Cancelled
    KALIE-CHEMIE PHARMA GMBH
    1986-08-08
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.